Prudential Financial
CNST

Prudential Financial’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Prudential Financial’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-61,199
Closed -$1.43M – 2643
2021
Q1 		$1.43M Buy
61,199
+21,125
+53% +$640K ﹤0.01% 1644
2020
Q4 		$1.15M Buy
40,074
+11,759
+42% +$296K ﹤0.01% 1683
2020
Q3 		$573K Buy
28,315
+8,191
+41% +$200K ﹤0.01% 1902
2020
Q2 		$605K Buy
+20,124
New +$725K ﹤0.01% 1849

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prudential Financial's CNST Position: Q2 2021 in Review

Prudential Financial sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 61,199 shares — an estimated $1.43M sold.

Prudential Financial first reported a position in CNST in Q2 2020 and held it in 4 quarters. The position peaked at $1.43M in Q1 2021. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • Prudential Financial reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Prudential Financial sold 61,199 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $1.43M.
  • Prudential Financial first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 4 quarters.
  • Prudential Financial's Constellation Pharmaceuticals, Inc. position peaked at $1.43M in Q1 2021.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Prudential Financial's 13F filing for Q2 2021, filed 16 Aug 2021.